DONGFENG GROUP(HK:00489) Ren Min Ri Bao·2025-08-15 22:00Core Viewpoint - Wuhan's biotechnology company, He Yuan Bio-Tech, has received approval for its recombinant human albumin injection, which will benefit patients with liver cirrhosis and low albumin levels, reflecting the city's vibrant innovation in manufacturing [1] Traditional Industry Transformation and Upgrading - Dongfeng Motor Corporation, based in Wuhan, has developed a new energy vehicle equipped with the DF30 chip, which has passed cold climate testing and is set for mass production next year [1] - The high-tech manufacturing sector in Wuhan saw a 15.7% year-on-year increase in value added, accounting for 24.6% of the total industrial value added in the first half of the year [1] New Industry Development and Expansion - Wuhan's automotive industry is a pillar sector, with new energy vehicle production exceeding 168,000 units in the first half of the year, marking a 152% year-on-year increase [2] - The optical electronics industry in Wuhan, known as "China's Optics Valley," has seen significant advancements, with the optical fiber industry reaching a scale of over 600 billion yuan [2][3] Future Industry Focus and Layout - Wuhan is making strides in the field of brain-computer interfaces, having launched medical service pricing for this technology and completed the first implant surgery in Central China [4] - The city aims to establish a competitive future industry development hub by focusing on 13 key areas, including brain-computer interfaces and humanoid robots [4] Government and Policy Support - The establishment of a joint innovation consortium for automotive-grade chips in Hubei province highlights the collaborative efforts between government, industry, and academia to drive technological advancements [2] - Wuhan's government emphasizes the importance of technological innovation in building a modern industrial system and aims for high-quality development [5]